
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Keratin 24 CRISPR/Cas9 KO Plasmid (h) | sc-414948 | 20 µg | $397.00 |
KRT24 encodes keratin 24, a type I intermediate filament protein that contributes to the cytoskeletal network in epithelial cells and supports tissue-specific structural integrity and mechanical resilience. As part of keratin filament assembly and remodeling, KRT24 integrates with broader cytoskeleton- and adhesion-linked processes that influence cell shape, polarity, and barrier function. Altered keratin expression patterns are commonly associated with epithelial stress responses and changes in differentiation state, making KRT24 a useful marker and mechanistic entry point for studying epithelial remodeling in disease-relevant contexts. Dysregulated intermediate filament organization can affect signaling cross-talk and cellular homeostasis, providing rationale to interrogate KRT24 in models of epithelial dysfunction.
Keratin 24 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the KRT24 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the KRT24 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the KRT24 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Keratin 24 protein expression.
This CRISPR knockout system enables efficient generation of KRT24-deficient cell models for investigation of Keratin 24 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.